Search

everythinglearnresearchcommunity

for

Search:↓

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Poly-L-lactic acid injections can cause hair loss and skin issues.

Applying minoxidil can help improve hair growth in people with hair loss caused by LIPH gene mutations.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

A new genetic variant in the LIPH gene causes hair growth issues in a Chinese patient.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

The best treatments for slowing down pattern hair loss are minoxidil and finasteride, with some other drugs and hair transplantation also used.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Optimized microneedles promote hair regrowth better than minoxidil without safety risks.

The MLPH gene is not linked to seasonal hair loss in Rhodesian Ridgeback dogs.

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.